Covid - 19

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 16

COVID -19

MADE BY : - 

RASHI SONI
COVID -19
• Coronavirus disease 2019 (COVID-19) is a contagious disease. The first case was identified in Wuhan, China,
in December 2019. This disease can spread in Air and water. 
• Symptoms of COVID-19 are variable, but often include fever, cough, fatigue, breathing difficulties, and  loss of
smell and taste. Symptoms begin one to fourteen days after exposure to the virus. Older people are more likely to
have severe symptoms. At least a third of the people who are infected with the virus remain asymptomatic and do
not develop noticeable symptoms at any point in time, but they still can spread the disease.  The virus that causes
COVID-19 spreads mainly when an infected person is in close contact with another person.
• We can prevent this disease by Face coverings, social distancing, hand washing and vaccination.
• COVID-19 spreads from person to person mainly through the respiratory route after an infected person coughs,
sneezes, sings, talks or breathes. A new infection occurs when virus-containing particles exhaled by an infected
person, either respiratory droplets or aerosols, get into the mouth, nose, or eyes of other people who are in close
contact with the infected person.
PREVENTIVE MEASURES OF COVID - 19
• Wear a mask to protect yourself and others and stop the spread of COVID-19. 
• Staying away from outbreak spots  is the best preventive measure against the possibility
of infection with COVID-19.
• Hand washing is also the best preventive measure against the possibility of infection
with COVID-19.
• Staying at least three feet away from other people if people have any symptoms. 
•  The best preventive measures is also staying away from areas of infection.
SYMPTOMS OF COVID - 19
 Symptoms of COVID – 19 are : -
• Fever or chills
• Shortness of breath or difficulty breathing
• Fatigue
• Muscle or body aches
• Headache and cough
• New loss of taste or smell
• Sore throat
• Congestion or runny nose
• Nausea or vomiting
• Diarrhea
A B O U T C O V I D – 1 9 PA N D E M I C
• The COVID-19 pandemic, also known as the coronavirus pandemic, is an
ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2. It was first identified in December 2019 in Wuhan, China. The World Health
Organization declared the outbreak a Public Health Emergency of International Concern in January 2020 and
a pandemic in March 2020.
• Symptoms of COVID-19 are highly variable, ranging from none to life-threatening illness. The
virus spreads mainly through the air when people are near each other.  It leaves an infected person as they
breathe, cough, sneeze, or speak and enters another person via their mouth, nose, or eyes. It may also spread
via contaminated surfaces. People remain infectious for up to two weeks, and can spread the virus even if they
do not show symptoms.
Covid – 19 Pandemic 
C O V I D - 1 9 VA C C I N E
• A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory
syndrome coronavirus 2, the virus causing coronavirus disease 2019 (COVID‑19). Prior to the COVID‑19
pandemic, there was an established body of knowledge about the structure and function
of coronaviruses causing diseases like severe acute respiratory syndrome and Middle East respiratory
syndrome, which enabled accelerated development of various vaccine technologies during early 2020. On 10
January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID, and by 19 March, the
global pharmaceutical industry announced a major commitment to address COVID-19. Many countries have
implemented phased distribution plans that prioritize those at highest risk of complications, such as the elderly,
and those at high risk of exposure and transmission, such as healthcare workers. As of 13 March 2021,
355.16 million doses of COVID‑19 vaccine have been administered worldwide based on official reports from
national health agencies. COVID‑19, a vaccine for an infectious disease had never been produced in less than
several years — and no vaccine existed for preventing a coronavirus infection in humans.
COVID –
19
VA C C I N E S
C O V I D – 1 9 VA C C I N AT I O N

• COVID –19 VACCINATION : -

  INDIA AND CANADA


  UNITED KINGDOM AND STATES
  ITALY AND AUSTRALIA
VA C C I N A T I O N O F I N D I A A N D C A N A D A
• India • Canada
On 16 January 2021 India started its national vaccination The COVID-19 vaccination programme in
programme against the SARS-CoV-2 virus which has Canada is an ongoing, intergovernmental effort
caused the COVID-19 pandemic. The drive prioritises coordinated between the bodies responsible in
healthcare and frontline workers, and then those over the the Government of Canada and the
age of 60, and then those over the age of 45 and suffering individual Provincial and Territorial governments to
from certain comorbidities. According to health officials, acquire, distribute and administer approved COVID-
India has administered 2,99,08,038 vaccine doses across 19 vaccine during the COVID-19 pandemic in
the country as of 14 March 2021. India has target Canada. The vaccination effort is the largest such
of Immunisation of Indians against COVID-19. immunization effort in the nation's history.
VA C C I N A T I O N O F U N I T E D K I N G D O M
A N D S TAT E
• United Kingdom • United States
The COVID-19 vaccination programme in the United The COVID-19 vaccination campaign in the United
Kingdom is the world's first States is an ongoing mass immunization campaign that
mass immunisation campaign to protect against SARS- was initiated by the American government under the
CoV-2 using vaccines developed in response to presidency of Donald Trump in order to respond to
the COVID-19 pandemic. The two vaccines currently in the COVID-19 pandemic in the United States. It started
use were developed by partnerships on December 14, 2020, with a goal to have the vaccine
between Pfizer and BioNTech and the University of widely available to the public by May 2021.  The
Oxford and AstraZeneca. A third, approved but not yet global competition had national security implications
being administered, was developed by Moderna.  for various countries.
VA C C I N A T I O N O F I T A L Y A N D A U S T R A L I A

• Italy • Australia
The COVID-19 vaccination campaign in Italy is COVID-19 vaccination in Australia began on Sunday
a mass immunization campaign that was put in place by 21 February 2021, and will continue throughout the
the Italian government in order to respond to year with the goal of vaccinating all willing Australians
the ongoing COVID-19 pandemic. before 2022. Front-line workers and aged care staff and
residents will be the first Australians to be inoculated,
 It started on 27 December 2020, together with most before a gradual phased release to less-vulnerable and
countries in the European Union. The vaccination lower-risk population groups throughout 2021. As of 13
campaign was managed by the Ministry of Health and March 2021, Australia has
the special commissioner Domenico Arcuri until 1 administered 164,782 vaccine doses across the country. 
March 2021, when he was replaced by Army
General Francesco Paolo Figliuolo.

You might also like